Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
前收盤價
US$3.14
−US$0.08 · -2.48%
盤中時間採用ET。市場資料可能有所延遲。
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
日內區間
目前US$3.14
52週區間
目前US$3.14
盤中時間採用ET。市場資料可能有所延遲。
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
日內區間
目前US$3.14
52週區間
目前US$3.14
近期已公布業績
近期已公布業績
報告持有此股票曝險的交易所交易基金。
iShares Russell 2000 ETFIWM557.33萬0.01%715.37億 USD0.19%US$256.61—
Vanguard Morningstar Total Stock Market ETFVTI417.39萬0.00%6893億 USD0.03%US$340.02—
Fidelity Enhanced Small Cap ETFFESM333.41萬0.05%67.4億 USD0.28%US$41.85—
iShares Russell 2000 Growth ETFIWO204.13萬0.02%127.32億 USD0.24%US$320.43—
Vanguard Extended Market ETFVXF172.77萬0.00%302億 USD0.05%US$211.44—
Dimensional - US Small Cap ETFDFAS163.65萬0.01%312.35億 USD0.30%US$74.24—
iShares Biotechnology ETFIBB116.94萬0.01%——US$199.54—
Vanguard Russell 2000 ETFVTWO96.39萬0.01%168億 USD0.06%US$103.76—
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Fidelity Enhanced Small Cap ETFFESM
iShares Russell 2000 Growth ETFIWO
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
iShares Biotechnology ETFIBB
Vanguard Russell 2000 ETFVTWOAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。